Zimmer Biomet had a strong 2024, bolstering its product lines and staying on top of orthopedic medtech trends.

WARSAW, Ind., Dec. 4, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) ...

Zimmer Biomet received FDA Premarket Approval Application Supplement approval for the Oxford Cementless Partial Knee implant. The implant is the only FDA-approved cementless partial knee implant in ...

Medical technology company Zimmer Biomet has received approval from the U.S. Food and Drug Administration for its Oxford cementless partial knee, making it the first implant of its kind available ...

WARSAW, Ind., Nov. 21, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will participate in the Citi Global ...

Medicare typically covers hip replacement surgery after a doctor confirms it is medically necessary. However, the extent of the coverage can depend on numerous factors. Hip replacement surgery can ...

Pfizer, seeking to equalize outcomes, taps Patrick Dempsey to shepherd cancer patients to resources Schwarzenegger, who has had a hip replaced, said Zimmer Biomet’s focus on maximizing mobility ...